We are live on ! Find out more
SCM

Shelton Capital Management Portfolio holdings

AUM $4.57B
1-Year Est. Return 32.26%
This Fund
S&P 500
This Quarter Est. Return
+6.56%
1 Year Est. Return
+32.26%
3 Year Est. Return
+110.31%
5 Year Est. Return
+153.06%
10 Year Est. Return
+630.09%
AUM
$3.68B
AUM Growth
+$162M
Cap. Flow
+$16.3M
Cap. Flow %
0.44%
Top 10 Hldgs %
35.65%
Holding
775
New
35
Increased
133
Reduced
392
Closed
59

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$12.1M
2
MSFT icon
Microsoft
MSFT
+$11.3M
3
TRMB icon
Trimble
TRMB
+$8.95M
4
C icon
Citigroup
C
+$7.74M
5
UNH icon
UnitedHealth
UNH
+$6.61M

Sector Composition

Rank Sector Weight
1 Technology 42.3%
2 Communication Services 12.12%
3 Consumer Discretionary 11.05%
4 Healthcare 8.43%
5 Industrials 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KHC icon
151
Kraft Heinz
KHC
$30B
$4.84M 0.13%
150,340
DDOG icon
152
Datadog
DDOG
$84B
$4.83M 0.13%
37,275
+977
+3% +$118K
CL icon
153
Colgate-Palmolive
CL
$74.4B
$4.82M 0.13%
49,664
+10,000
+25% +$922K
ARMK icon
154
Aramark
ARMK
$14.7B
$4.81M 0.13%
141,474
-605
-0.4% -$19.6K
ODFL icon
155
Old Dominion Freight Line
ODFL
$44.9B
$4.78M 0.13%
27,044
ON icon
156
ON Semiconductor
ON
$31.6B
$4.72M 0.13%
68,839
+1,513
+2% +$106K
EXC icon
157
Exelon
EXC
$47B
$4.66M 0.13%
134,784
EA
158
DELISTED
Electronic Arts
EA
$4.64M 0.13%
33,303
-3,100
-9% -$408K
LULU icon
159
lululemon athletica
LULU
$14.6B
$4.61M 0.13%
15,437
XYL icon
160
Xylem
XYL
$28.1B
$4.61M 0.13%
33,957
-5,000
-13% -$680K
CORT icon
161
Corcept Therapeutics
CORT
$12B
$4.56M 0.12%
+140,494
New +$3.85M
FANG icon
162
Diamondback Energy
FANG
$52.7B
$4.52M 0.12%
22,582
+574
+3% +$114K
VMI icon
163
Valmont Industries
VMI
$9.53B
$4.5M 0.12%
16,398
-93
-0.6% -$22.7K
FAST icon
164
Fastenal
FAST
$59.5B
$4.49M 0.12%
142,858
-14
-0% -$472
DAR icon
165
Darling Ingredients
DAR
$9.44B
$4.49M 0.12%
122,061
-322
-0.3% -$13.4K
GEHC icon
166
GE HealthCare
GEHC
$32.4B
$4.46M 0.12%
57,291
MCK icon
167
McKesson
MCK
$101B
$4.45M 0.12%
7,622
BKR icon
168
Baker Hughes
BKR
$61.1B
$4.43M 0.12%
126,005
FSLR icon
169
First Solar
FSLR
$26.9B
$4.32M 0.12%
19,172
-14,100
-42% -$3.07M
ULTA icon
170
Ulta Beauty
ULTA
$24.3B
$4.32M 0.12%
11,191
ACM icon
171
Aecom
ACM
$9.75B
$4.25M 0.12%
48,252
-10,318
-18% -$941K
ETN icon
172
Eaton
ETN
$174B
$4.13M 0.11%
13,182
-13,000
-50% -$4.2M
STZ icon
173
Constellation Brands
STZ
$23.2B
$4.13M 0.11%
16,056
+11,500
+252% +$2.96M
FIS icon
174
Fidelity National Information Services
FIS
$22.1B
$4.06M 0.11%
53,906
+12,900
+31% +$955K
CCEP icon
175
Coca-Cola Europacific Partners
CCEP
$47.9B
$4.04M 0.11%
55,492
+1,956
+4% +$141K

Similar funds

Shelton Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Shelton Capital Management held 775 positions worth $3.68B, up 4.6% from $3.52B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Shelton Capital Management's Q2 2024 filing shows 35 new, 133 increased, 392 reduced and 59 closed positions. Its largest new stake was Corcept Therapeutics: 140,494 shares worth $4.56M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $22.4M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 39% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Shelton Capital Management's largest Q2 2024 buy was Corcept Therapeutics: 140,494 shares worth $4.56M.
  • Shelton Capital Management added most to NVIDIA in Q2 2024, an estimated $12.1M increase.
  • Shelton Capital Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $22.4M.
  • Shelton Capital Management fully exited Brookfield Renewable in Q2 2024, selling an estimated $4.6M.
  • Shelton Capital Management's ten largest holdings make up 36% of its $3.68B portfolio in Q2 2024.
  • Shelton Capital Management opened 35 new positions and closed 59 in Q2 2024.
  • Shelton Capital Management's portfolio value rose 4.6% quarter-over-quarter to $3.68B.

Based on Shelton Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.